Patents by Inventor Xia Bu

Xia Bu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Media stream sending method and apparatus, and device
    Patent number: 12107697
    Abstract: A media stream sending method provides a live media stream for a client that enters a live broadcast room. A proxy server receives, from a first client, a first live broadcast room request message for requesting to enter the live broadcast room; the proxy server determines a role of the first client based on the first live broadcast room request message; and if the role of the first client is a slave user, the proxy server sends a first live media stream cached in the proxy server to the first client, where the first live media stream is a media stream that is sent by a media server to a second client through the proxy server, and a role of the second client is a master user.
    Type: Grant
    Filed: July 26, 2021
    Date of Patent: October 1, 2024
    Assignee: HUAWEI TECHNOLOGIES CO., LTD.
    Inventors: Naiqiang Qiao, Xia Zhu, Jun Zhou, Qi Bu
  • ANTI-PHOSPHOTYROSINYLATED PROGRAMMED DEATH 1 (PD-1) MONOCLONAL ANTIBODIES, METHODS OF MAKING AND METHODS OF USING THEREOF
    Publication number: 20230331847
    Abstract: The present invention is based, in part, on the discovery of monoclonal and polyclonal antibodies that specifically bind to phosphorylated PD-1, as well as immunoglobulins, polypeptides, nucleic acids thereof, and methods of using such antibodies for diagnostic, prognostic, and therapeutic purposes.
    Type: Application
    Filed: September 22, 2022
    Publication date: October 19, 2023
    Inventors: Gordon J. Freeman, Vassiliki A. Boussiotis, Xia Bu, Vikram R. Juneja, Arlene H. Sharpe, Nikolaos Patsoukis, Jessica Weaver, Laura Strauss
  • Anti-phosphotyrosinylated programmed death 1 (PD-1) monoclonal antibodies, methods of making and methods of using thereof
    Patent number: 11492403
    Abstract: The present invention is based, in part, on the discovery of monoclonal and polyclonal antibodies that specifically bind to phosphorylated PD-1, as well as immunoglobulins, polypeptides, nucleic acids thereof, and methods of using such antibodies for diagnostic, prognostic, and therapeutic purposes.
    Type: Grant
    Filed: April 20, 2018
    Date of Patent: November 8, 2022
    Assignees: Dana-Farber Cancer Institute, Inc., Beth Israel Deaconess Medical Center, President and Fellows of Harvard College
    Inventors: Gordon J. Freeman, Vassiliki A. Boussiotis, Xia Bu, Vikram R. Juneja, Arlene H. Sharpe, Nikolaos Patsoukis, Jessica Weaver, Laura Strauss
  • ANTI-PHOSPHOTYROSINYLATED PD-1 ANTIBODIES AND USES THEREOF
    Publication number: 20200115452
    Abstract: The present invention is based, in part, on the discovery of monoclonal and polyclonal antibodies that specifically bind to phosphorylated PD-1, as well as immunoglobulins, polypeptides, nucleic acids thereof, and methods of using such antibodies for diagnostic, prognostic, and therapeutic purposes.
    Type: Application
    Filed: April 20, 2018
    Publication date: April 16, 2020
    Inventors: Gordon J. Freeman, Vassiliki A. Boussiotis, Xia Bu, Vikram R. Juneja, Arlene H. Sharpe, Nikolaos Patsoukis, Jessica Weaver, Laura Straus